Amgen Inc (AMGN)

226.43 +1.65  +0.73% NASDAQ May 22, 20:00 Delayed 2m USD

Amgen Profit Margin (Quarterly):

29.62% for March 31, 2020
View 4,000+ financial data types
Browse...
View Full Chart

Profit Margin (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Profit Margin (Quarterly) Data

View and export this data going back to 1984. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2020 29.62%
Dec. 31, 2019 27.48%
Sept. 30, 2019 34.30%
June 30, 2019 37.11%
March 31, 2019 35.85%
Dec. 31, 2018 30.95%
Sept. 30, 2018 31.49%
June 30, 2018 37.89%
March 31, 2018 41.61%
Dec. 31, 2017 -73.49%
Sept. 30, 2017 35.01%
June 30, 2017 37.02%
March 31, 2017 37.90%
Dec. 31, 2016 32.44%
Sept. 30, 2016 34.71%
June 30, 2016 32.88%
March 31, 2016 34.38%
Dec. 31, 2015 32.51%
Sept. 30, 2015 32.55%
June 30, 2015 30.78%
March 31, 2015 32.25%
Dec. 31, 2014 24.27%
Sept. 30, 2014 24.73%
June 30, 2014 29.86%
March 31, 2014 23.73%
   
Dec. 31, 2013 20.38%
Sept. 30, 2013 28.81%
June 30, 2013 26.89%
March 31, 2013 33.84%
Dec. 31, 2012 17.82%
Sept. 30, 2012 25.63%
June 30, 2012 28.28%
March 31, 2012 29.25%
Dec. 31, 2011 23.51%
Sept. 30, 2011 11.51%
June 30, 2011 29.55%
March 31, 2011 30.36%
Dec. 31, 2010 26.61%
Sept. 30, 2010 32.39%
June 30, 2010 31.60%
March 31, 2010 32.49%
Dec. 31, 2009 24.44%
Sept. 30, 2009 36.36%
June 30, 2009 34.18%
March 31, 2009 30.80%
Dec. 31, 2008 21.78%
Sept. 30, 2008 29.88%
June 30, 2008 25.00%
March 31, 2008 31.44%
Dec. 31, 2007 22.30%

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Benchmarks

Benchmarks
Gilead Sciences Inc 27.96%
Johnson & Johnson 28.01%
Merck & Co Inc 26.70%

Profit Margin (Quarterly) Range, Past 5 Years

Minimum -73.49% Dec 2017
Maximum 41.61% Mar 2018
Average 28.65%
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.